The PLATO trial reveals further opportunities to improve outcomes in patients with acute coronary syndrome. Editorial on Serebruany. “Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified” (Thromb Haemost 2011; 105.5) - Wallentin, L; Becker, RC; James, SK (Thromb Haemost, 2011)
et al.